BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2013
View Archived Issues
Transmission and infectivity of emerging H7N9 influenza virus studied in animal models
Read More
Phase II results presented for ARA-290 in rheumatoid arthritis
Read More
Updated phase I/II results for daratumumab in advanced MM
Read More
DARA BioSciences grants DB-959 worldwide rights to T3D Therapeutics
Read More
FDA accepts RHB-103 NDA for review
Read More
Isotechnika Pharma receives additional funding for anti-HCV agent
Read More
Aurigene and Debiopharm nominate anticancer development candidate
Read More
Athera and Boehringer Ingelheim sign option agreement for novel preclinical antibody program
Read More
Optical probe presented for molecular imaging of bacterial infections
Read More
Clinical trial data presented for a TGFR-1 inhibitor
Read More
CollabRx forms cancer translational research collaboration with University of Chicago Medical Center
Read More
AOP Orphan spins off stake in Activartis
Read More
BELLUS Health enters agreement to acquire Thallion Pharmaceuticals
Read More
Senesco reports further results from phase Ib/IIa SNS01-T trial
Read More
Life Technologies signs agreement to develop siRNA therapeutics in China
Read More
Hangzhou Bensheng Pharmaceutical patents new agents for cancer
Read More
Sarepta Therapeutics reports updated 84-week data from phase IIb eteplirsen study
Read More
Researchers at Roche disclose new LRRK2 inhibitors
Read More
Sanofi synthesizes new CXCR3 receptor antagonists
Read More
Pfizer presents novel anti-IL-4/IL-13 bifunctional molecule with promising activity
Read More
FDA issues drug safety communication for Zyprexa Relprevv
Read More
Raptor launches Procysbi in the U.S.
Read More
Target enrollment reached in phase II trial of CCX-140 in diabetic nephropathy
Read More
FDA advisory committee sets date to review Amarin's sNDA for Vascepa
Read More
Vaxart reports phase I findings for oral H1N1 influenza vaccine
Read More